Thiabendazole Effectiveness In Creeping Eruption
ORVILLE J. STONE, MD;
J. FRED MULLINS, MD
Arch Dermatol. 1965;91(5):427-429.
Abstract
Thiabendazole, when used in doses of 50 mg/kg daily for two days or 25 mg/kg/b.i.d for two days permanently stops the activity of over 99% of the larvae on the first day of therapy.
The series is still small enough to make it difficult to evaluate the various dosage schedules for their relative incidence of side effects. Probably the least side effects will occur with 25 mg/kg twice daily for two days.
The side effects apparently result from a central nervous system effect of the drug. Dizziness precedes any nausea or vomiting. The patients who vomited still had excellent therapeutic results. To date, the side effects were not a serious enough handicap to limit the use of the drug.
The limitations of applicability of in vitro testing with nematode larvae are discussed.
Author Affiliations
GALVESTON, TEX
From the Department of Dermatology, University of Texas Medical Branch. Professor (Dr. Mullins) and Assistant Professor (Dr. Stone).
Footnotes
Accepted for publication Jan 12, 1965.
Reprint requests to Department of Dermatology, University of Texas Medical Branch, Galveston, Tex 77551 (Dr. Stone).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Creeping Eruption: A Review of Clinical Presentation and Management of 60 Cases Presenting to a Tropical Disease Unit
Davies et al.
Arch Dermatol 1993;129:588-591.
ABSTRACT
Thiabendazole-Induced Toxic Epidermal Necrolysis
Robinson and Samorodin
Arch Dermatol 1976;112:1757-1760.
ABSTRACT
Treatment of Creeping Eruption With Topical Thiabendazole
Davis and Israel
Arch Dermatol 1968;97:325-326.
ABSTRACT
Topical Thiabendazole for Creeping Eruption
KATZ and HOOD
Arch Dermatol 1966;94:643-645.
ABSTRACT
Effect of Thiabendazole on Ancylostoma caninum
STONE et al.
Arch Dermatol 1965;92:59-62.
ABSTRACT
|
